Short Reads


Georg Casari, who co-founded Lion Bioscience in 1997 and before that worked in high-throughput sequencing at EMBL and the EBI, became vice president of informatics at Cellzome in Heidelberg.


Taylor Crouch resigned from his position as president and CEO of pharmacogenomics firm Variagenics. Joseph Mohr, former VP of marketing and business development, was appointed president and CBO, while CFO Richard Shea took on the role of COO.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.